Liver Illness and Psoriatic Patients.
Fiore M, Leone S, Maraolo AE, Berti E, Damiani G.
Biomed Res Int. 2018 Feb 6;2018:3140983. doi: 10.1155/2018/3140983. eCollection 2018.
36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N, Rajas O, Briones M, Rodríguez de Castro F, Rodríguez Gallego C, Esen F, Orhun G, Ergin Ozcan P, Senturk E, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Kucukerden M, Giris M, Akcan U, Bilgic Gazioglu S, Tuzun E, Riff R, Naamani O, Douvdevani A, Takegawa R, Yoshida H, Hirose T, Yamamoto N, Hagiya H, Ojima M, Akeda Y, Tasaki O, Tomono K, Shimazu T, Ono S, Kubo T, Suda S, Ueno T, Ikeda T, Hirose T, Ogura H, Takahashi H, Ojima M, Kang J, Nakamura Y, Kojima T, Shimazu T, Ikeda T, Suda S, Izutani Y, Ueno T, Ono S, Taniguchi T, O M, Dinter C, Lotz J, Eilers B, Wissmann C, Lott R, Meili MM, Schuetz PS, Hawa H, Sharshir M, Aburageila M, Salahuddin N, Chantziara V, Georgiou S, Tsimogianni A, Alexandropoulos P, Vassi A, Lagiou F, Valta M, Micha G, Chinou E, Michaloudis G, Kodaira A, Ikeda T, Ono S, Ueno T, Suda S, Izutani Y, Imaizumi H, De la Torre-Prados MV, Garcia-De la Torre A, Enguix-Armada A, Puerto-Morlan A, Perez-Valero V, Garcia-Alcantara A, Bolton N, Dudziak J, Bonney S, Tridente A, Nee P, Nicolaes G, Wiewel M, Schultz M, Wildhag…
Crit Care. 2016 Apr 20;20(Suppl 2):94. doi: 10.1186/s13054-016-1208-6.
Antifungal agents and liver toxicity: a complex interaction.
Tverdek FP, Kofteridis D, Kontoyiannis DP.
Expert Rev Anti Infect Ther. 2016 Aug;14(8):765-76. doi: 10.1080/14787210.2016.1199272. Epub 2016 Jun 23.
The Rise and Fall of Oral Ketoconazole.
Gupta AK, Lyons DC.
J Cutan Med Surg. 2015 Jul-Aug;19(4):352-7. doi: 10.1177/1203475415574970. Epub 2015 Mar 5.
Mold and Human Health: a Reality Check.
Borchers AT, Chang C, Eric Gershwin M.
Clin Rev Allergy Immunol. 2017 Jun;52(3):305-322. doi: 10.1007/s12016-017-8601-z.
Safety aspects of ketoconazole, the most commonly used systemic antifungal.
Cauwenbergh G.
Mycoses. 1989;32 Suppl 2:59-63. doi: 10.1111/j.1439-0507.1989.tb02312.x.
Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis.
Girois SB, Chapuis F, Decullier E, Revol BG.
Eur J Clin Microbiol Infect Dis. 2006 Feb;25(2):138-49. doi: 10.1007/s10096-005-0080-0.
Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis.
Girois SB, Chapuis F, Decullier E, Revol BG.
Eur J Clin Microbiol Infect Dis. 2005 Feb;24(2):119-30. doi: 10.1007/s10096-005-1281-2.
Protective antifungal yeast killer toxin-like antibodies.
Magliani W, Conti S, Frazzi R, Ravanetti L, Maffei DL, Polonelli L.
Curr Mol Med. 2005 Jun;5(4):443-52. doi: 10.2174/1566524054022558.
In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs.
Nosratabadi M, Faeli L, Haghani I, Mohammadi R, Khodavaisy S, Kachuei R, Katiraee F, Aghili SR, Shokohi T, Hedayati MT, Nazeri M, Javan-Nikkhah M, Zarrinfar H, Javidnia J, Najafzadeh MJ, Salimi M, M S Al Hatmi A, Badali H, Abastabar M.
Mycoses. 2023 Mar;66(3):258-275. doi: 10.1111/myc.13550. Epub 2022 Dec 19.
